Regulatory effects of microRNA-184 on osteosarcoma via the Wnt/-catenin signaling pathway

被引:21
作者
Du, Zhenguang [1 ]
Li, Fusheng [1 ]
Wang, Liangliang [1 ]
Huang, Hai [1 ]
Xu, Shaonian [1 ]
机构
[1] Peoples Hosp Liaoning, Dept Orthoped, 33 Wenyi Rd, Shenyang 110016, Liaoning, Peoples R China
关键词
microRNA-184; osteosarcoma; Wnt; -catenin; U-2OS cells; 143B cells; ARTICLE. SEE APRIL; CELL-PROLIFERATION; IN-VITRO; PROMOTES PROLIFERATION; INVASION; CANCER; IDENTIFICATION; METASTASIS; MIR-184; CHEMOTHERAPY;
D O I
10.3892/mmr.2018.9184
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study aimed to investigate the role of microRNA (miRNA/miR)-184 in osteosarcoma growth, development and metastasis, and the effects of miRNA-184 on the proliferation, invasion and metastasis of osteosarcoma cells and associated mechanisms. In vitro, miR-184 was transfected into U-2OS cells and 143B cells. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to detect the expression of miR-184. MTT was utilized to detect cell proliferation. A Transwell assay was applied to detect cell invasiveness. In vivo, an osteosarcoma tibial orthotopic metastatic tumor model was established, and western blotting and RT-qPCR were used to detect the expression of Wnt and -catenin. Following the overexpression of miR-184, the proliferation and cell invasion ability were significantly increased in U-2OS and 143B cells. Following inhibition of miR-184, cell proliferation and cell invasion ability were significantly decreased. In nude mice, tumor volume significantly increased following overexpression of miR-184, and Wnt and phosphorylated -catenin levels were significantly increased. Following miR-184 inhibition, tumor volume was significantly decreased, and Wnt and phosphorylated -catenin levels were significantly decreased. The results of the present study indicated that the Wnt/-catenin signaling pathway serves a key function in the mechanism of osteosarcoma. Inhibition of miRNA-184 may reduce tumor volume of osteosarcoma via regulation of the Wnt/-catenin signaling pathway and may provide a novel strategy for the future diagnosis and treatment of osteosarcoma.
引用
收藏
页码:1917 / 1924
页数:8
相关论文
共 42 条
[1]   Enhanced mitochondrial biogenesis contributes to Wnt induced osteoblastic differentiation of C3H10T1/2 cells [J].
An, Jee Hyun ;
Yang, Jae-Yeon ;
Ahn, Byung Yong ;
Cho, Sun Wool ;
Jung, Ju Yeon ;
Cho, Hwa Young ;
Cho, Young Min ;
Kim, Sang Wan ;
Park, Kyong Soo ;
Kim, Seong Yeon ;
Lee, Hong Kyu ;
Shin, Chan Soo .
BONE, 2010, 47 (01) :140-150
[2]   β-arrestin is a necessary component of Wnt/β-catenin signaling in vitro and in vivo [J].
Bryja, Vitezslav ;
Gradl, Dietmar ;
Schambony, Alexandra ;
Arenas, Ernest ;
Schulte, Gunnar .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (16) :6690-6695
[3]   Inactive Wnt/β-catenin pathway in conventional high-grade osteosarcoma [J].
Cai, Yongping ;
Mohseny, Alexander B. ;
Karperien, Marcel ;
Hogendoorn, Pancras C. W. ;
Zhou, Gengyin ;
Cleton-Jansen, Anne-Marie .
JOURNAL OF PATHOLOGY, 2010, 220 (01) :24-33
[4]   Identification and analysis of key genes in osteosarcoma using bioinformatics [J].
Diao, Chunyu ;
Xi, Yong ;
Xiao, Tao .
ONCOLOGY LETTERS, 2018, 15 (03) :2789-2794
[5]   Review of Osteosarcoma and Current Management [J].
Durfee R.A. ;
Mohammed M. ;
Luu H.H. .
Rheumatology and Therapy, 2016, 3 (2) :221-243
[6]   TUMOR MEASUREMENT IN THE NUDE-MOUSE [J].
EUHUS, DM ;
HUDD, C ;
LAREGINA, M ;
JOHNSON, FE .
JOURNAL OF SURGICAL ONCOLOGY, 1986, 31 (04) :229-234
[7]  
Feng R, 2015, INT J CLIN EXP PATHO, V8, P9376
[8]   miR-184 functions as an oncogenic regulator in hepatocellular carcinoma (HCC) [J].
Gao, Bo ;
Gao, Kuanjiang ;
Li, Li ;
Huang, Zhicheng ;
Lin, Li .
BIOMEDICINE & PHARMACOTHERAPY, 2014, 68 (02) :143-148
[9]   Primary malignant bone tumors-recent developments [J].
Hameed, Meera ;
Dorfman, Howard .
SEMINARS IN DIAGNOSTIC PATHOLOGY, 2011, 28 (01) :86-101
[10]   microRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R [J].
Han, Kang ;
Zhao, Tingbao ;
Chen, Xiang ;
Bian, Na ;
Yang, Tongtao ;
Ma, Qiong ;
Cai, Chengkui ;
Fan, Qingyu ;
Zhou, Yong ;
Ma, Baoan .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (04) :1437-1449